Clinical Trial

A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy and safety of TQC2731 injection in patients with moderate to severe chronic obstructive pulmonary disease.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-11-26; most recent amendment 2025-12-10.
Status change: Recruiting → Active, Not Recruiting 2025-12-10
Status change: Not Yet Recruiting → Recruiting 2025-01-06
Trial Details
NCT Number NCT06707883
Lead Sponsor Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Conditions Chronic Obstructive Pulmonary Disease
Enrollment 258 participants
Start Date 2024-12-31
Primary Completion 2026-12 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-12-12